Company / Capital Returned to Shareholders per Share
Medpace Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$29.95
FY2025
5-year range
$1.75 / $29.95
FY2021-FY2025
Trend
+442.2%
vs FY2024
Sector context
#5 of 108
Health Care
What the data says
Capital Returned to Shareholders per Share changed +442% YoY in FY2025, a notable deviation from the 6-year average annual change of +75%.
Based on SEC 10-K filings.
29.95 in FY2025 with a 5-year CAGR of +61.5%. Top quartile in the Health Care sector.
Improved from $4.63 to $29.95 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +122.2%
- 5-Year CAGR
- +61.5%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 108This company $29.95 Sector average $4.89
▼
+512.7% above sector average
Key checks
Key Insights
- Medpace's capital returned to shareholders per share has grown for 4 consecutive years.
- In FY2025, capital returned to shareholders per share increased 442.2% year-over-year.
- Ranks #5 out of 108 companies in the Health Care sector.
- Lowest capital returned to shareholders per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 147.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.95 | +442.2% |
| FY2024 | $5.52 | +19.2% |
| FY2023 | $4.63 | +69.7% |
| FY2022 | $2.73 | +56.1% |
| FY2021 | $1.75 | -35.8% |
| FY2020 | $2.72 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | -100.0% |
| FY2017 | $3.83 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026